Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 7/20 | 0.33 |
| ▸ | HDAC4 | P56524 | 5/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | ELANE | P08246 | 2/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.31 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.31 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30367749 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HDAC1HDAC4HDAC6MAPT | |
| SCHEMBL16047481 | 0.94 | HDAC1 (0.36) | ALDH1A1HDAC1HDAC4HDAC6HDAC2 | |
| SCHEMBL5051961 | 0.93 | HDAC1 (0.33) | ALDH1A1HDAC1HDAC4HDAC6HDAC2 | |
| SCHEMBL2033142 | 0.90 | ALDH1A1 (0.45) | ALDH1A1MAPTKMT2APOLBLMNA | |
| SCHEMBL44111 | 0.89 | HPGD (0.37) | ALDH1A1HDAC1HDAC4HDAC6MAPT | |
| SCHEMBL29361373 | 0.89 | HPGD (0.37) | ALDH1A1HDAC1HDAC4HDAC6MAPT | |
| SCHEMBL19713428 | 0.86 | HPGD (0.35) | HDAC1HDAC4HDAC6HDAC2LMNA | |
| SCHEMBL5499529 | 0.86 | ALDH1A1 (0.39) | ALDH1A1HDAC1HDAC4HDAC6MAPT | |
| SCHEMBL12056750 | 0.85 | HPGD (0.36) | HDAC1HDAC4HDAC6HDAC2 | |
| SCHEMBL7200996 | 0.85 | POLB (0.34) | ALDH1A1MAPTKMT2APOLBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4499712-A2 | TARGETED DELIVERY | Judo Bio Inc. (US) | 2025-02-05 | — | — | EP | disclosed |
| CN-113039191-B | Nucleotide analogues | 奇异基因组学系统公司 | 2024-07-16 | — | — | CN | disclosed |
| WO-2023183628-A9 | TARGETED DELIVERY | JUDO BIO INC. (US) | 2023-11-30 | — | — | WO | disclosed |
| WO-2023183628-A2 | TARGETED DELIVERY | JUDO BIO INC. (US) | 2023-09-28 | — | — | WO | disclosed |
| US-20100273724-A1 | PEGYLATED ION CHANNEL MODULATING COMPOUNDS | CARDIOME PHARMA CORP. (CA) | 2010-10-28 | — | — | US | disclosed |
| US-7786119-B2 | Drug conjugates of ion channel modulating compounds | CARDIOME PHARMA CORP. (CA) | 2010-08-31 | — | — | US | disclosed |
| US-20080021005-A1 | Pegylated Ion Channel Modulating Compounds | CARDIOME PHARMA CORP. (CA) | 2008-01-24 | — | — | US | disclosed |
| US-7238799-B2 | Mustang, a gene and nuclear protein | RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK AT STONY BROOK (US) | 2007-07-03 | — | — | US | disclosed |
| US-20050164206-A1 | Mustang, a novel gene and nuclear protein | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2005-07-28 | — | — | US | disclosed |
| EP-0941738-B1 | Antigenic conjugates of conserved lipooligosaccharides of gram negative bacteria | WYETH CORP (US) | 2005-05-11 | — | — | EP | disclosed |
| US-20040248081-A1 | LANA viral protein binding sites | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2004-12-09 | — | — | US | disclosed |
| US-20040052804-A1 | Antigenic conjugates of conserved lipopolysaccharides of gram negative bacteria | WYETH HOLDINGS CORPORATION | 2004-03-18 | — | — | US | disclosed |
| US-6645503-B1 | Eliciting a cross reactive immune response against heterologous strains of the gram negative bacteria; vaccines; comprises the inner core and lipid A portions of the lipopolysaccharide | WYETH HOLDINGS CORPORATION | 2003-11-11 | — | — | US | disclosed |
| US-20030133948-A1 | Methods to inhibit or enhance the binding of viral DNA to genomic host DNA | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2003-07-17 | — | — | US | disclosed |
| US-6482587-B1 | Methods to inhibit or enhance the binding of viral DNA to genomic host DNA | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2002-11-19 | — | — | US | disclosed |
| WO-2001025484-A2 | METHODS TO INHIBIT OR ENHANCE THE BINDING OF VIRAL DNA TO GENOMIC HOST DNA | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2001-04-12 | — | — | WO | disclosed |
| US-6200801-B1 | A POLYCATION AND A BINDING MOIETY OF DEFINED AMINO ACID SEQUENCE CAPABLE OF BINDING TO A SERPIN ENZYME COMPLEX RECEPTOR FOR TARGETED GENE DELIVERY; GENE THERAPY; ANTISENSE AGENTS | CASE WESTERN RESERVE UNIVERSITY | 2001-03-13 | — | — | US | disclosed |
| US-5972901-A | MAKING A COMPOSITION FOR DELIVERING AN OLIGONUCLEOTIDE TO A MAMMALIAN CELL BY PROVIDING A PEPTIDE TARGET BINDING MOIETY BEING CAPABLE OF BINDING TO A SERPIN ENZYME COMPLEX RECEPTOR, POLYLYSINE, AN OLIGONUCLEOTIDE VECTOR; CONJUGATING, COUPLING | CASE WESTERN RESERVE UNIVERSITY (US) | 1999-10-26 | — | — | US | disclosed |
| EP-0941738-A1 | Antigenic conjugates of conserved lipopolysaccharides of gram negative bacteria | American Cyanamid Company (US) | 1999-09-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080021005-A1 | Pegylated Ion Channel Modulating Compounds | KCNN3, KCNN2, KCNN1 | ALDH1A1 2835/4885HDAC1 1767/4885HDAC4 1653/4885 |
| US-20100273724-A1 | PEGYLATED ION CHANNEL MODULATING COMPOUNDS | KCNN3, KCNN2, KCNN1 | ALDH1A1 2835/4885HDAC1 1767/4885HDAC4 1653/4885 |
| US-20040052804-A1 | Antigenic conjugates of conserved lipopolysaccharides of gram negative bacteria | LY96, DDOST, LRBA | ALDH1A1 4023/4885HDAC1 2949/4885HDAC4 2640/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.